Novel biomarkers for improving diagnostics, prognostics, and treatments of Alzheimer´s disease

Project: Research

Project Details

Description

In this ERC-funded project, we use novel biomarkers and imaging methods to improve the development of novel disease-modifying therapies for Alzheimer’s disease.
AcronymADVANCE-AD
StatusActive
Effective start/end date2024/01/01 → 2028/12/31

Funding

  • European Commission - Horizon Europe
  • Swedish Research Council